Boletín de la Sociedad Peruana de Medicina Interna - Vol. 12 Nº1 - 1999

 

BIBLIOGRAFÍA

  • National Society to Prevent Blindness. Vision problems in the U.S. Data analysis, definitions, data sources, detail data tables, analyses, interpretation. New York; National Sociaty to Prevent Bindness 1980.

  • National Society to Prevent Blindness. Vision problems in the U.S.: Facts and Figures. Feb. 1980.

  • Seclén S, Vargas R y Col. Prevalencia DM, HTA, Hipercolesterolemia y Obesidad como factores de riesgo. Premio Roussel 1997.

  • Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color findus photographs an extension of the Modmed Airlie House classification. ETDRS. Report 10. Ophthalmology, 1991; 98: 786? 806.

  • Diabetes Mellitus en el Perú. Rolando Calderón Velasco, José Benigno Peñaloza. Editorial Deza, Lima 1996.

  • Klein R, y Col. The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 1984; 102: 527-532.

  • Wong, C: Salud ocular y ceguera en el Perú. Archivos Peruanos de Oftalmol. Volumen 8: Suplemento 14,16,20-21. 1996.

  • Gerónimo, F y Wong, C: La ceguera en la población de Lima Arch. Per. Oftalmol. 6(1): 30?33, 1994.

  • Wong, C: Enfermedades oculares y ceguera en el Perú. Estudio Epidemiológico. Arch. Per. Oftalmol. 7(l): 45-67, 1995.

  • Tenorio, A: Causas de pensión de invalidez por enfermedad conidn en Oftalinologia. Rev. Per. Oftalmol. XVI (1): 18?20, 1991.

  • Wong, C y Toledo, J: Prevención de Ceguera: La Ceguera en Lima. Estudio en 1600 casos. Rev. Per. Oftalmol. VIII (1): 314-320, 1978.

  • Wong, C; Calderón, M y Ardiles C: La ceguera en la edad senil. Rev. Per Oftalmol. IX (2): 72.-75, 1983.

  • Ballard DJ, y Col. Risk factors for diabetic retinopathy. Diabetes Care 1986; 9:334-342.

  • Segal P, y Col. Prevelence of diabetic retinopathy. Diabetes Care 1983; 6:149-151.

  • Klein R, y Col. Wisconsin Epidemiologic Study of Diabetic Retinopathy. IV. Diabetes Macular Edema. Ophthalmol. 1984; 1464-1474.

  • Chew EY, y Col ETDRS. Association of elevated serum lipids with retinal hard exudate in diabetic retinopathy. Arch Ophthalmol. 1996; 114: 1079-1084.

  • Klein R, y Col. The epidemiology of proliferative diabetic retinopathy. Diabetes Care. 1992; 15:1875.1891.

  • Nielsen NV. DR II. The course of retinopathy in diabetics treated with oral hypoglycemic agents and diet regime alone. A three years epidemiological cohort. Study of Diabetes Mellitus. Acta Ophthalmol. 1984; 62:266

  • Moss SE, Klein R, Klein Beck The incidence of visions loss in a diabetic population. Ophthalmol. 1988; 95: 1340-1348

  • Segal P, Treister G, et al. The prevalence of DR: effect of sex, age, duration of disease and mode of theraphy. Diabetes care. 1983; 6: 149-151.

  • Klein R. The epidemiology of DR: Findings from the Wisconsin Epidemiologic study of DR. International Ophthalmology Clinics 1987; 27: 230-238.

  • ETDRS Research Group. Photocoagulation for diabetic macular edema. Arch Ophthalmol. 1985; 103: 1796-1806.

  • Deutsch TA, O'Riordan JF, Ernest JT, et al. Systemic blood pressure and diabetic macular edema. ARVO Abstracts. Invest. Ophthalmol. Vis Sci 1983; 24 (Suppl):80.

  • R. Joseph OLK, carol M. Lee. Diabetic Retinopathy, practical management JB, Lippicott 1993.

  • Licea Puig, Manuel Lemane Pérez, y col. Rev. Cuba Med; 27 (4): 48-54 1988.

  • Sigler Villanueva, Aldo; Jiménez Barredo, Jesús y col. Análisis de algunas variables clínicas en relación con la RD. Rev. Cuba. Oftalmol; 9 (2): 122-7, 1996.